Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1217)
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
5,030
Price
$80.00
Total Value
$402.39K
Shares Held After
23,296
% of Holdings
17.8%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
14,321
Price
$79.11
Total Value
$1.13M
Shares Held After
28,326
% of Holdings
33.6%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
749
Price
$2.02
Total Value
$1.51K
Shares Held After
68,028
% of Holdings
1.1%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
474
Price
$2.02
Total Value
$957.48
Shares Held After
15,434
% of Holdings
3.0%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$29.76
Total Value
$60.53K
Shares Held After
235,626
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
233
Price
$187.84
Total Value
$43.77K
Shares Held After
405,796
% of Holdings
0.1%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
2,608
Price
$186.73
Total Value
$487.00K
Shares Held After
406,029
% of Holdings
0.6%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,159
Price
$186.09
Total Value
$587.84K
Shares Held After
408,637
% of Holdings
0.8%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
5,394
Price
$2.02
Total Value
$10.89K
Shares Held After
263,693
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
1,635
Price
$22.40
Total Value
$36.62K
Shares Held After
85,034
% of Holdings
1.9%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
15,000
Price
$23.01
Total Value
$345.15K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,518
Price
$16.33
Total Value
$106.44K
Shares Held After
583,911
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
24,423
Price
$15.49
Total Value
$378.31K
Shares Held After
590,429
% of Holdings
4.0%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
48,044
Price
$15.30
Total Value
$735.07K
Shares Held After
15,394
% of Holdings
75.7%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
13,555
Price
$18.22
Total Value
$246.91K
Shares Held After
145,355
% of Holdings
8.5%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
200
Price
$18.45
Total Value
$3.69K
Shares Held After
55,286
% of Holdings
0.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$18.16
Total Value
$81.73K
Shares Held After
205,141
% of Holdings
2.1%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
12,892
Price
$18.16
Total Value
$234.16K
Shares Held After
209,641
% of Holdings
5.8%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
327
Price
$1.06
Total Value
$346.62
Shares Held After
66,848
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
421
Price
$507.09
Total Value
$213.49K
Shares Held After
130
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
132
Price
$506.16
Total Value
$66.81K
Shares Held After
551
% of Holdings
19.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
908
Price
$505.06
Total Value
$458.59K
Shares Held After
683
% of Holdings
57.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
730
Price
$503.99
Total Value
$367.91K
Shares Held After
1,591
% of Holdings
31.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$503.03
Total Value
$105.64K
Shares Held After
2,321
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$501.93
Total Value
$190.23K
Shares Held After
2,531
% of Holdings
13.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$500.96
Total Value
$247.98K
Shares Held After
2,910
% of Holdings
14.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$499.85
Total Value
$528.85K
Shares Held After
3,405
% of Holdings
23.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,371
Price
$498.95
Total Value
$684.07K
Shares Held After
4,463
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,075
Price
$498.01
Total Value
$535.36K
Shares Held After
5,834
% of Holdings
15.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
407
Price
$496.71
Total Value
$202.16K
Shares Held After
6,909
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
555
Price
$495.87
Total Value
$275.21K
Shares Held After
7,316
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$494.75
Total Value
$336.43K
Shares Held After
7,871
% of Holdings
8.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
456
Price
$493.71
Total Value
$225.13K
Shares Held After
8,551
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
340
Price
$492.53
Total Value
$167.46K
Shares Held After
9,007
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
283
Price
$491.68
Total Value
$139.15K
Shares Held After
9,347
% of Holdings
2.9%
LIGAND PHARMACEUTICALS INC (LGND)
Sabba Stephen L — Director
Shares
2,034
Price
$201.50
Total Value
$409.85K
Shares Held After
33,793
% of Holdings
5.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
14,233
Price
$16.52
Total Value
$235.13K
Shares Held After
1,155,291
% of Holdings
1.2%
Xencor Inc (XNCR)
Dahiyat Bassil I — Director
Shares
6,758
Price
$11.90
Total Value
$80.39K
Shares Held After
567,792
% of Holdings
1.2%
Xencor Inc (XNCR)
Eckert Celia — SVP, GENERAL COUNSEL
Shares
1,492
Price
$11.90
Total Value
$17.75K
Shares Held After
81,929
% of Holdings
1.8%
Xencor Inc (XNCR)
Desjarlais John R — SR. VICE PRESIDENT & CSO
Shares
2,663
Price
$11.90
Total Value
$31.68K
Shares Held After
270,451
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
359
Price
$321.58
Total Value
$115.45K
Shares Held After
21,860
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
722
Price
$320.51
Total Value
$231.41K
Shares Held After
22,219
% of Holdings
3.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
282
Price
$318.62
Total Value
$89.85K
Shares Held After
22,941
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
289
Price
$316.55
Total Value
$91.48K
Shares Held After
23,223
% of Holdings
1.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
463
Price
$321.50
Total Value
$148.85K
Shares Held After
23,406
% of Holdings
1.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
640
Price
$320.48
Total Value
$205.11K
Shares Held After
23,869
% of Holdings
2.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
317
Price
$319.06
Total Value
$101.14K
Shares Held After
24,509
% of Holdings
1.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
355
Price
$316.74
Total Value
$112.44K
Shares Held After
24,826
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,519
Price
$69.33
Total Value
$451.98K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
13,481
Price
$68.85
Total Value
$928.17K
Shares Held After
774,299
% of Holdings
1.7%
Showing 901–950 of 1217 transactions (page 19 of 25)